Endothelial Cell Loss and Induced Astigmatism After Wound-directed and Wound-assisted IOL Injection

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT01250964
Collaborator
(none)
72
1
2
7
10.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if there is any difference in astigmatism (eye surface curvature) or corneal endothelial cell density (the inner cell lining of the eye surface) after two different methods for inserting a lens during cataract surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lens insertion during cataract surgery
N/A

Detailed Description

Cataract surgery (removal of a cloudy lens) is currently performed through increasingly smaller incisions. Bimanual surgery, where two instruments are used to remove the lens, is performed through two 1.4 mm incisions. Typically, one of these incisions is enlarged to 2.2 or 2.4 mm in order that the IOL (artificial lens) can be inserted into the eye. Surgeons insert these lenses by placing a lens injector cartridge completely into the eye (wound-directed insertion) or by placing only the tip inside the incision (wound-assisted insertion). While wound-assisted insertion can be performed through slightly smaller incisions (2.2 mm versus 2.4 mm for wound-directed insertion), both methods of insertion cause some incision enlargement. There is some evidence that wound-assisted insertion can cause very short-term pressure within the eye to go up. Neither method is considered inferior or superior to the other, and the primary investigator (Dr. Kenneth Cohen) routinely uses both methods.

No studies have directly compared wound-healing characteristics between these two methods. We seek to compare differences in:

  1. Surgically-induced astigmatism (changes in the corneal curvature from cataract surgery incisions.

  2. Endothelial cell density loss. Endothelial cells line the inside surface of the cornea, and their overall density can be decreased by cataract surgery.

  3. Best-corrected vision after surgery

  4. Sizes of the incisions after lens injection

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Endothelial Cell Loss and Surgically Induced Astigmatism After 2.2 mm Wound Assisted vs 2.4 mm Wound-Directed Clear Corneal Incisions for Intraocular Lens Insertion During Cataract Surgery
Study Start Date :
Apr 1, 2010
Actual Primary Completion Date :
Nov 1, 2010
Actual Study Completion Date :
Nov 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Wound-assisted lens injection

Wound-assisted lens injection is considered neither superior or inferior to wound-directed lens injection.

Procedure: Lens insertion during cataract surgery
After cataract removal during cataract surgery, a lens needs to be injected into the eye. Both arms are routinely used but different methods for injecting the lens.

Active Comparator: Wound-directed lens injection

Wound-directed lens injection is neither considered superior nor inferior to wound-assisted lens injection.

Procedure: Lens insertion during cataract surgery
After cataract removal during cataract surgery, a lens needs to be injected into the eye. Both arms are routinely used but different methods for injecting the lens.

Outcome Measures

Primary Outcome Measures

  1. Surgically induced astigmatism [1 month]

    measured by topography at 1 month post operative visit

Secondary Outcome Measures

  1. Endothelial cell loss [one month]

    As measured by specular microscopy

  2. Best corrected visual acuity [one month]

    By manifest refraction

  3. Final incision size [intraoperatively (day #0)]

    measured with incision gauges before and after lens injection.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Eligible patients include those who undergo uncomplicated cataract extraction surgery and IOL implantation by KLC.
Exclusion Criteria: Patients who:
  1. suffer from diabetes and have more than mild background diabetic retinopathy,

  2. have a history of intraocular surgery,

  3. have a history of ocular trauma,

  4. have known pathology of the cornea,

  5. have a history of intraocular inflammation,

  6. are unable to understand English,

  7. are decisionally impaired,

  8. are currently incarcerated, or

  9. are less than 18 years of age.

No exclusions will be made on the basis of gender, ethnicity, or race.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kittner Eye Center Chapel Hill North Carolina United States 27599

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Kenneth Cohen, MD, UNC dept. of ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01250964
Other Study ID Numbers:
  • 10-0435
First Posted:
Dec 1, 2010
Last Update Posted:
Dec 1, 2010
Last Verified:
Nov 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2010